Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial

Autor: Megan K. Yee, C. Michael Gibson, Tarek Nafee, Mathieu Kerneis, Yazan Daaboul, Serge Korjian, Gerald Chi, Fahad AlKhalfan, Adrian F. Hernandez, Russell D. Hull, Alexander T. Cohen, Samuel Z. Goldhaber

Publikováno v: TH Open, Vol 03, Iss 02, Pp e103-e108 (2019)

Abstract Background Among medically ill patients treated with thromboprophylaxis, betrixaban was not associated with an increase in major bleeding compared with enoxaparin, but an increase in clinically relevant non-major (CRNM) bleeding was observ

Externí odkaz: https://doaj.org/article/4614910b1fea4dacb011d257a64a6386

A low dose heparinized saline protocol is associated with improved duration of arterial line patency in critically ill COVID-19 patients

Autor: Laura Prout, Lydia R. Maurer, Kerry Breen, Haytham M.A. Kaafarani, Kelly Newman, Rachel P. Rosovsky, Arzo Hamidi, Majed El Hechi, Casey M. Luckhurst, Megan E Barra, Laura Lux, David C. Chang, Russel J. Roberts, Jarone Lee, Ava Mokhtari, Edward A. Bittner

Publikováno v: Journal of Critical Care

Purpose Critically ill patients with Coronavirus Disease 2019 (COVID-19) have high rates of line thrombosis. Our objective was to examine the safety and efficacy of a low dose heparinized saline (LDHS) arterial line (a-line) patency protocol in this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8787a1993def0a8151c1d3661ce69e4
https://pubmed.ncbi.nlm.nih.gov/32920504

Clinically relevant non-major bleeding with oral anticoagulants: non-major may not be trivial

Autor: Franco, Laura, Becattini, Cecilia, Vanni, Simone, Sbrojavacca, Rodolfo, Nitti, Cinzia, Manina, Giorgia, Masotti, Luca, Pomero, Fulvio, Cattinelli, Sergio, Cappelli, Roberto, Roberta, Re, Agnelli, Giancarlo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a6feb4c9a40e18431939025a0f889480
http://hdl.handle.net/11365/1033109

Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial.

Autor: Yee MK; Boston Clinical Research Institute, Newton, Massachusetts, United States., Gibson CM; Boston Clinical Research Institute, Newton, Massachusetts, United States., Nafee T; Boston Clinical Research Institute, Newton, Massachusetts, United States., Kerneis M; PERFUSE Study Group, Division of Cardiovascular, Departments of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States., Daaboul Y; PERFUSE Study Group, Division of Cardiovascular, Departments of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States., Korjian S; PERFUSE Study Group, Division of Cardiovascular, Departments of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States., Chi G; PERFUSE Study Group, Division of Cardiovascular, Departments of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States., AlKhalfan F; PERFUSE Study Group, Division of Cardiovascular, Departments of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States., Hernandez AF; Duke University and Duke Clinical Research Institute, Durham, North Carolina, United States., Hull RD; Division of Cardiology, R.A.H. Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada., Cohen AT; Department of Haematological Medicine, Guy's and St Thomas' Hospitals, London, United Kingdom., Goldhaber SZ; Division of Cardiovascular, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

Publikováno v: TH open : companion journal to thrombosis and haemostasis [TH Open] 2019 Apr 17; Vol. 3 (2), pp. e103-e108. Date of Electronic Publication: 2019 Apr 17 (Print Publication: 2019).